This content is machine translated Benign prostatic hyperplasia Phytotherapeutic combination preparation inhibits inflammation and reduces tissue growth Several clinical studies support the efficacy of a phytopharmacologic sabal/urica combination for the treatment of obstructive and irritative lower urinary tract symptoms (LUTS) in the setting of benign prostatic hyperplasia.…
View Post 4 min This content is machine translated Biomarkers and immunotherapy New horizons in advanced prostate cancer Metastatic castration-resistant prostate cancer (mCRPC) has been considered primarily the domain of novel hormone and taxane therapy. Increasingly, however, other treatment approaches are being tested with sometimes promising results. In…
View Post 6 min This content is machine translated News from the world of oncology The hottest studies at a glance Every year, ESMO presents the most relevant research results of its congress within the framework of so-called Presidential Symposia. Also at this year’s virtual execution, the presentation of those studies…
View Post 5 min This content is machine translated Therapy of overactive bladder Minimize side effect risks and increase compliance Anticholinergics are among the standard pharmacological therapies for overactive bladder. It is important to choose the right preparation for each patient. The side effect risks vary considerably in some cases.…
View Post 1 min This content is machine translated Cystitis When going to the toilet becomes a pain! About 50-70% of all women have cystitis at least once a year. Repeated bladder infections occur in approximately 5-10% of cases. Phytotherapeutic preparations based on nasturtium and horseradish can provide…
View Post 3 min This content is machine translated Hyperkalemia How the Guideline Comes to the Bedside: Hyperkalemia Management Up to Date Patients with chronic heart or kidney failure often suffer from hyperkalemia. The use of RAAS inhibitors in particular may increase the risk of this life-threatening electrolyte disturbance. Therefore, therapy of…
View Post 8 min This content is machine translated Urothelial carcinoma of the urinary bladder A challenge even in times of immune checkpoint inhibitors Urothelial carcinoma accounts for 90% of urinary bladder tumors. Every year, 1250 people in Switzerland contract the disease – predominantly older men. Standard treatment is cisplatin-containing chemotherapy. Immunotherapy is playing…
View Post 2 min This content is machine translated Bladder Cancer Immunotherapy after chemo may prolong survival Carcinoma of the urinary bladder is one of the common malignant diseases. While the prognosis of patients with superficial tumors is usually favorable, the situation is much worse for muscle-infiltrating…
View Post 3 min This content is machine translated Benign prostatic hyperplasia Countering proliferation and inflammation naturally Benign prostatic hyperplasia is a common urological condition caused by non-malignant enlargement of the prostate. About one-third of men over 40 report lower urinary tract problems in this context. A…
View Post 1 min This content is machine translated Advanced bladder cancer Prolonged progression-free survival with combination therapy Preliminary study results suggest that the addition of immunotherapy to conventional chemotherapy may improve progression-free survival in patients with advanced bladder cancer. Is a paradigm shift on the horizon?
View Post 3 min This content is machine translated Benign prostatic hyperplasia Inhibition of inflammation as a central mechanism of action Sage palmetto fruit and nettle root extract has been repeatedly shown to be effective for the treatment of benign prostatic hyperplasia. Recent studies have focused on the anti-inflammatory properties of…
